Cleveland HeartLab, Inc., often referred to as CHL, is a leading player in the cardiovascular diagnostics industry, headquartered in the United States. Founded in 2011, the company has rapidly established itself as a pioneer in advanced heart health testing, focusing on innovative solutions that enhance patient care and outcomes. With a strong operational presence across major regions in the US, Cleveland HeartLab offers a comprehensive range of services, including advanced lipid testing and inflammation assessments. Their unique approach combines cutting-edge technology with a commitment to personalised medicine, setting them apart in a competitive market. Recognised for their contributions to cardiovascular health, Cleveland HeartLab has achieved significant milestones, including partnerships with healthcare providers and a growing portfolio of proprietary tests. Their dedication to improving heart health continues to position them as a trusted resource for clinicians and patients alike.
How does Cleveland HeartLab, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cleveland HeartLab, Inc.'s score of 31 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cleveland HeartLab, Inc., headquartered in the US, currently does not report specific carbon emissions data for the latest year, as indicated by the absence of emissions figures. The company is a current subsidiary of Quest Diagnostics Incorporated, which may influence its climate commitments and reporting practices. As part of its corporate family, Cleveland HeartLab's climate initiatives and performance may be aligned with those of Quest Diagnostics. However, specific reduction targets or achievements have not been disclosed for Cleveland HeartLab. The absence of documented reduction initiatives or Science Based Targets (SBTi) suggests that the company may still be in the early stages of formalising its climate strategy. Given the lack of specific emissions data and reduction commitments, Cleveland HeartLab's climate impact remains unclear. The company may benefit from adopting industry-standard climate practices and setting measurable targets to enhance its sustainability profile in the future.
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 83,929,000 | 00,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 145,724,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 41,299,000 | 00,000,000 | 00,000,000 | - | 000,000,000 | 000,000,000 |
Cleveland HeartLab, Inc.'s Scope 3 emissions, which decreased by 23% last year and increased significantly since 2015, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 77% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 54% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cleveland HeartLab, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.